PortfoliosStock ScreensStocksStockXcel

Repligen Corporation

RGEN | US

117.60

USD

3.54

3.10%

RGEN | US
Loading StockChartView...

About Repligen Corporation

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2024

As of date

24/04/2026

Close

117.60

Open

115.15

High

118.31

Low

111.45

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America Europe the Asia Pacific and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening viral clearance validation studies and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition the company provides filtration products such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes which are used in downstream biologic drug concentration buffer exchange and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products and ProConnex TFDF flow paths. Further it provides process analytics products such as slope spectroscopy systems under the SoloVPE FlowVPE and FlowVPX brands. The company sells its products to life sciences biopharmaceutical and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham Massachusetts.

View Less

RGEN | US

Risk
56.2
Sharpe
-0.49
Luna's Score
40/100
Recommendation
Sell

Luna says (RGEN | US)

What's Working

Strength based on increasing price with high volume

What's not Working

Price Below SMA10D

High Short-term Volatility

Midcap (2B - 10B USD)

High Market Beta (> 0.8)

Weak Operating Margin (< 10%)

Declining Revenue (< 0%)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

Loading RiskMeterView...

10 days

70.0%

1 month

56.2%

3 months

46.5%

6 months

41.5%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

-

Fwd. PE

82.64

Price to book

4.14

Debt to equity

0.37

Debt to assets

0.26

Ent. to EBITDA

88.78

Ent. to rev.

13.55

PEG

2.59

Other Fundamentals

EBITDA

78.94M

MarketCap

6.59B

MarketCap(USD)

6.59B

Div. yield

-

Op. margin

1.60

Erngs. growth

-83.00

Rev. growth

-3.20

Ret. on equity

-0.10

Short ratio

4.25

Short perc.

7.94

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

31.93

Range1M

31.93

Range3M

60.26

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

1.34

Price X volume

145.16M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Grifols S.AGRFSBiotechnology8.086.31B1.13%33.27190.24%
Arcellx Inc. Common StockACLXBiotechnology115.036.18B-0.02%n/a15.25%
Praxis Precision Medicines IncPRAXBiotechnology344.826.12B4.62%n/a0.46%
Tilray IncTLRYDrug Manufacturers-Specialty & Generic6.756.10B-2.74%n/a6.83%
Protagonist Therapeutics IncPTGXBiotechnology1005.89B-2.55%17.272.03%
Amarin Corporation plcAMRNBiotechnology14.315.88B-1.92%n/a1.47%
Erasca Inc. Common StockERASBiotechnology21.495.84B-4.36%n/a11.96%
Lyell Immunopharma Inc. Common StockLYELBiotechnology22.415.74B-5.04%n/a10.63%
TG Therapeutics IncTGTXBiotechnology36.625.67B-0.81%34.2863.38%
Alkermes plcALKSBiotechnology33.315.49B-1.77%12.4028.66%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
FBINFBINBuilding Products & Equipment41.545.16B0.34%25.57130.24%
Thor Industries IncTHORecreational Vehicles794.18B0.24%23.4427.88%
VeriFone Systems IncPAYBuilding Products & Equipment27.253.39B0.96%102.462.10%
Polaris Industries IncPIIRecreational Vehicles60.043.35B1.06%14.48170.51%
LCI IndustriesLCIIRecreational Vehicles120.013.06B-0.45%25.8277.66%
Harley-Davidson IncHOGRecreational Vehicles23.113.04B-1.15%7.33218.58%
Pitney Bowes IncPBIBuilding Products & Equipment15.582.80B1.37%n/a-571.93%
HNI CorporationHNIBuilding Products & Equipment37.71.78B1.32%22.1276.47%
ARLO TECHNOLOGIES INCARLOBuilding Products & Equipment14.61.46B3.03%n/a19.46%
Lincoln Educational Services CorporationLINCBuilding Products & Equipment39.111.23B-1.21%51.6088.92%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA88.780.53Expensive
Ent. to Revenue13.553,967.00Cheaper
PE Ratio-41.03-
Price to Book4.1415.55Cheaper
Dividend Yield-2.20-
Std. Deviation (3M)46.4672.80Lower Risk
Debt to Equity0.37-1.23Expensive
Debt to Assets0.260.25Par
Market Cap6.59B3.66BMarket Leader
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007